Radio and PodcastRadio and PodcastLive Radio & Podcasts
JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma artwork
Science & Medicine

JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma

Journal of Clinical Oncology (JCO) Podcast by Journals Online Team

Jun 1, 202612:05Science & Medicine

JCO Podcast host Dr. Davide Soldato and JCO Associate Editor Dr. Dr. Eileen M. O'Reilly discuss the ASCO 2026 Simultaneous Publication paper " Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast...

About This Episode

JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma is an episode from Journal of Clinical Oncology (JCO) Podcast by Journals Online Team. JCO Podcast host Dr. Davide Soldato and JCO Associate Editor Dr. Dr. Eileen M...

Podcast

This episode belongs to Journal of Clinical Oncology (JCO) Podcast.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Jun 1, 2026, 12:05 long, audio available.

Related Episodes

Continue listening to more episodes from Journal of Clinical Oncology (JCO) Podcast.